BOHMOVA, Jana, Marek LUBUSKY, Iva HOLUSKOVA, Martina STUDNICKOVA, Romana KRATOCHVILOVA, Eva KREJCIRIKOVA, Veronika DURDOVA, Tereza KRATOCHVILOVA, Ladislav DUŠEK, Martin PROCHAZKA and Radek VODICKA. Two Reliable Methodical Approaches for Non-Invasive RHD Genotyping of a Fetus from Maternal Plasma. Diagnostics. Basel: MDPI, 2020, vol. 10, No 8, p. 1-15. ISSN 2075-4418. Available from: https://dx.doi.org/10.3390/diagnostics10080564.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Two Reliable Methodical Approaches for Non-Invasive RHD Genotyping of a Fetus from Maternal Plasma
Authors BOHMOVA, Jana (203 Czech Republic), Marek LUBUSKY (203 Czech Republic), Iva HOLUSKOVA (203 Czech Republic), Martina STUDNICKOVA (203 Czech Republic), Romana KRATOCHVILOVA (203 Czech Republic), Eva KREJCIRIKOVA (203 Czech Republic), Veronika DURDOVA (203 Czech Republic), Tereza KRATOCHVILOVA (203 Czech Republic), Ladislav DUŠEK (203 Czech Republic, belonging to the institution), Martin PROCHAZKA (203 Czech Republic) and Radek VODICKA (203 Czech Republic, guarantor).
Edition Diagnostics, Basel, MDPI, 2020, 2075-4418.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30218 General and internal medicine
Country of publisher Switzerland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 3.706
RIV identification code RIV/00216224:14110/20:00116484
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.3390/diagnostics10080564
UT WoS 000568020600001
Keywords in English non-invasive fetal genotyping; RHDgene; cell-free fetal DNA; real-time PCR; QF PCR; Rh blood group system; red blood cell alloimmunization; hemolytic disease of the fetus and newborn
Tags 14119612, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 24/9/2020 07:08.
Abstract
Noninvasive fetalRHDgenotyping is an important tool for predicting RhD incompatibility between a pregnant woman and a fetus. This study aimed to assess a methodological approach other than the commonly used one for noninvasive fetalRHDgenotyping on a representative set of RhD-negative pregnant women. The methodology must be accurate, reliable, and broadly available for implementation into routine clinical practice. A total of 337 RhD-negative pregnant women from the Czech Republic region were tested in this study. The fetalRHDgenotype was assessed using two methods: real-time PCR and endpoint quantitative fluorescent (QF) PCR. We used exon-7-specific primers from theRHDgene, along with internal controls. Plasma samples were analyzed and measured in four/two parallel reactions to determine the accuracy of theRHDgenotyping. TheRHDgenotype was verified using DNA analysis from a newborn buccal swab. Both methods showed an excellent ability to predict theRHDgenotype. Real-time PCR achieved its greatest accuracy of 98.6% (97.1% sensitivity and 100% specificity (95% CI)) if all four PCRs were positive/negative. The QF PCR method also achieved its greatest accuracy of 99.4% (100% sensitivity and 98.6% specificity (95% CI)) if all the measurements were positive/negative. Both real-time PCR and QF PCR were reliable methods for precisely assessing the fetalRHDallele from the plasma of RhD-negative pregnant women.
PrintDisplayed: 7/6/2024 03:51